News
Public · Published
TD Cowen maintains Exelixis at Buy, raises price target to $76 from $55
TD Cowen maintained a Buy rating on Exelixis and raised its price target to $76 from $55, a 38.2% increase. The new target implies 14.8% upside from the October 29 close of $66.20.
Published:
Updated:
What happened
TD Cowen maintained a Buy rating on Exelixis and raised its price target to $76 from $55, a 38.2% increase. The new target implies 14.8% upside from the October 29 close of $66.20.
Confirmed
Global impact / market context
A higher price target signals an analyst expects more share price gain ahead. For Exelixis holders, it supports confidence in near-term performance, but a target is an opinion, not a guarantee, and other analysts listed lower targets.
Analyst inference
Five other recent analyst notes on Exelixis carried targets from $54 to $65, below TD Cowen's $76. That gap shows divided views on the company's outlook, so investors may see the upgrade as a more bullish outlier rather than consensus.
Analyst inference
What to watch
- Watch whether other analysts change their Exelixis ratings or price targets after TD Cowen's move, since the five most recent notes ranged from $54 to $65. Confirmed
- Compare TD Cowen's $76 target with the October 29 close of $66.20 to judge how much further upside the analyst now expects from the stock. Proposed
- Track whether Exelixis shares move toward the $76 target, which would suggest investors accept TD Cowen's more bullish view over lower peer targets. Analyst inference
Evidence
- Original source link unavailable